| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sutro Biopharma, Inc. (STRO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 3 sells. STRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 25.0K | $790.5K | - | |
| Other | 7.9K | $250.6K | - | |
| CFO | 7.5K | $237.2K | - | |
| Other | 7.2K | $227.7K | - | |
| CEO | 5.0K | $158.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2019 | Hallam Trevor | Chief Science Officer | Sell | 975 | $10.68 | $10,410.27 | -3.7% | |
| Oct 28, 2019 | Hallam Trevor | Chief Science Officer | Sell | 975 | $9.98 | $9,726.11 | -3.5% | |
| Oct 1, 2018 | Petree Daniel H | Director | Sale+OE | 122 | $15.00 | $1,830.00 | -38.9% |